Study: Fecal Transplant Reduces Autism Symptoms by 50% – FDA Wants to Make it a Drug

A promising treatment has shown remarkable success in treating autism—but will the FDA turn it into a Big Pharma blockbuster? Recently we reported on the advancements in research regarding fecal microbiota transplants (FMT), which harness the power of the gut microbiome to treat illness. A recent study has found that FMT reduced autism symptoms by 50%. This is a stunning finding that provides further evidence of the incredible potential of FMT, but the FDA is on the verge of turning this affordable treatment into an expensive drug and thus potentially putting the treatment out of reach for many patients.

500 Previously Unknown Microorganisms and 800 Bacterial Viruses Mapped in Intestinal Flora

Researchers at the Technical University of Denmark report that they have identified and mapped 500 previously unknown microorganisms and more than 800 bacterial viruses in our intestinal flora. Researching gut flora and the "microbiome" is the new trend in research and medicine, as the age of antibiotics has passed. New antibiotic-resistant diseases present an enormous threat to global health. If you are not familiar with the term "microbiome", you soon will be. Hundreds of millions of dollars are being poured into researching the microbiome to develop new drugs and therapies. But are we really going to trust in the modern pharmaceutical industry to provide a new class of "microbiome" drugs to solve the problems they created in the first place? Or are there natural ways of restoring one's own microbiome without the "help" of the medical system?

The Most Effective Probiotic is Free but the FDA Wants to Ban It

The therapeutic use of human poop has proven to be more effective than very expensive pharmaceutical drugs for certain diseases. Fecal Microbiota Transplants (FMT) are a less expensive and more effective treatment for many common diseases, yet the FDA is limiting the use of this therapy. Fecal Microbiota Transplant therapy involves transplanting stool from a healthy person into the digestive system of an unhealthy person to cure specific diseases. FMT is helpful because the poop from a healthy person contains bacteria that is needed by the person who is sick. FMT has been successfully used for: drug-resistant bacterial infections such as Clostridium Difficile, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Crohn’s Disease, chronic constipation, Chronic Fatigue Syndrome (CFS), obesity, type II diabetes, Autism, Parkinson’s, mental disease, food poisoning, Malaria, Metabolic Syndrome, autoimmune diseases, and allergies. But this is a huge threat to the pharmaceutical industry, so the FDA has declared poop a drug and is making efforts to restrict it and ban donor banks.

As Fecal Transplants Cure and Save Lives, FDA Classifies Poop as a Drug and Restricts It

Fecal Microbiata Transplant (FMT) has been documented to cure disease and save lives. It has primarily been studied in treating anti-biotic resistant bacteria, such as Clostridium difficile where some doctors have reported a 100% success rate with no side effects. Because doctors were using fecal matter from healthy people to cure C. diff and other diseases, the FDA stepped in and declared fecal matter as a "drug." Since it is a drug they have not approved, it now officially in Phase 1 of the drug research and approval process, a process that can take many years. In a letter from the FDA to the American Gastroenterological Association (AGA), they stated that FMT is not to be used by physicians, other than in life saving situations subject to a formal IND (Investigational New Drug) application. So why would the FDA make the ridiculous claim that someone's healthy poop is a drug, and start regulating a safe therapy that has saved so many lives, cured so many with bowel diseases, and has virtually no recorded adverse effects?

Fecal Transplant Cures Antibiotic Resistant Infections – Will FDA Stop it?

Health Impact News Editor

A recent study published in the New England Journal of Medicine on fecal transplants curing Clostridium difficile bacteria made news across the nation recently. 14,000 people a year in the U.S. die from C. difficile, which is generally caused by the overuse of antibiotics which kills off all of the gut flora, including […]